Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease-free Survival”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Large-scale testing (Phase 3)Study completedNCT00022672
What this trial is testing

Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 208
Testing effectiveness (Phase 2)Active Not RecruitingNCT02008656
What this trial is testing

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 358
Not applicableNot Yet RecruitingNCT07455422
What this trial is testing

Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

Who this might be right for
Barrett EsophagusBarrett Esophagus AdenocarcinomaAdenocarcinoma - GEJ+2 more
University Hospital, Antwerp 266
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Not applicableStudy completedNCT07695974
What this trial is testing

Clinicopathological Predictors of Recurrence in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaRecurrence Free Survival
University of Roma La Sapienza 1,113
Not applicableStudy completedNCT02835027
What this trial is testing

Treatment of Acute Lower Limb Ischaemia in Sweden 1994-2014

Who this might be right for
Acute Ischemia of Lower Limb
Uppsala University Hospital 16,287
Not applicableUnknownNCT03810469
What this trial is testing

Foot Perfusion Analysis to Predict Limb Salvage

Who this might be right for
Critical Limb IschemiaPeripheral Arterial Disease
Centre Hospitalier de Valenciennes 69
Large-scale testing (Phase 3)UnknownNCT05111197
What this trial is testing

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Who this might be right for
Locally Advanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Institut Cancerologie de l'Ouest 112
Not applicableStudy completedNCT04661969
What this trial is testing

"Outcomes of Surgical Removal of Foreign Body Granulomas"

Who this might be right for
Foreign Body GranulomaSurgeryComplication
Hospital Angeles del Pedregal 35
Testing effectiveness (Phase 2)Study completedNCT00520403
What this trial is testing

Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 25
Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Not applicableStudy completedNCT03226912
What this trial is testing

The PREDICT Study- a Registry in Critically Ill Patients to Determine Predictors of Disability Free Survival

Who this might be right for
Critical IllnessMechanical Ventilation ComplicationDisabilities Multiple+5 more
Australian and New Zealand Intensive Care Research Centre 500
Post-approval studies (Phase 4)UnknownNCT02253511
What this trial is testing

A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zheng Donghai 400
Not applicableNot Yet RecruitingNCT07563088
What this trial is testing

SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic CarcinomaSinonasal Carcinoma
Eye & ENT Hospital of Fudan University 200
Not applicableStudy completedNCT06337279
What this trial is testing

Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk

Who this might be right for
Gastric Cancer
Fujian Medical University 3,820
Large-scale testing (Phase 3)Study completedNCT05290545
What this trial is testing

Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

Who this might be right for
Hematological MalignanciesHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 314
Testing effectiveness (Phase 2)UnknownNCT03799094
What this trial is testing

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clifford Hospital, Guangzhou, China 150
Large-scale testing (Phase 3)Study completedNCT01456351
What this trial is testing

Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
University of Giessen 230
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Next Page